KEY FEATURES
Full Name | Epiregulin |
---|---|
Synonym | EPR; ER; Proepiregulin |
Assay Type | Sandwich |
Reactivity | Human |
Range | 15.6-1000pg/mL |
Sensitivity | 6.2pg/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human EREG in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human EREG. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human EREG and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human EREG, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human EREG. You can calculate the concentration of Human EREG in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human EREG ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/mL) | 46.52 | 129.69 | 392.77 | 49.93 | 123.95 | 419.15 |
Standard deviation | 2.81 | 5.58 | 18.34 | 3.2 | 7.16 | 13.66 |
CV(%) | 6.05 | 4.3 | 4.67 | 6.41 | 5.78 | 3.26 |
RECOVERY
The recovery of Human EREG spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 85-96 | 90 |
EDTA plasma (n=8) | 84-97 | 90 |
Cell culture media (n=8) | 91-106 | 97 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human EREG in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with EREG ELISA Kits
AREG ELISA Kit | publications with EREG and AREG |
EGFR ELISA Kit | publications with EREG and EGFR |
HBEGF ELISA Kit | publications with EREG and HBEGF |
ERBB2 ELISA Kit | publications with EREG and ERBB2 |
ERBB4 ELISA Kit | publications with EREG and ERBB4 |
ERBB3 ELISA Kit | publications with EREG and ERBB3 |
NRG1 ELISA Kit | publications with EREG and NRG1 |
NRG2 ELISA Kit | publications with EREG and NRG2 |
NRG4 ELISA Kit | publications with EREG and NRG4 |
Pathways associated with EREG ELISA Kit
ARMS-mediated Activation Pathway | ARMS-mediated Activation Pathway |
Adaptive Immune System Pathway | Adaptive Immune System Pathway |
Axon Guidance Pathway | Axon Guidance Pathway |
Constitutive Signaling By Aberrant PI3K In Cancer Pathway | Constitutive Signaling By Aberrant PI3K In Cancer Pathway |
Cytokine Signaling In Immune System Pathway | Cytokine Signaling In Immune System Pathway |
DAP12 Interactions Pathway | DAP12 Interactions Pathway |
DAP12 Signaling Pathway | DAP12 Signaling Pathway |
Developmental Biology Pathway | Developmental Biology Pathway |
Disease Pathway | Disease Pathway |
Diseases Of Signal Transduction Pathway | Diseases Of Signal Transduction Pathway |
Diseases associated with EREG ELISA Kit
Adenocarcinoma | publications with EREG and Adenocarcinoma |
Inflammation | publications with EREG and Inflammation |
Breast Neoplasms | publications with EREG and Breast Neoplasms |
Lung Neoplasms | publications with EREG and Lung Neoplasms |
Lung Diseases | publications with EREG and Lung Diseases |
Necrosis | publications with EREG and Necrosis |
Neoplasms, Experimental | publications with EREG and Neoplasms, Experimental |
Cell Transformation, Neoplastic | publications with EREG and Cell Transformation, Neoplastic |
Cardiovascular Diseases | publications with EREG and Cardiovascular Diseases |
Liver Diseases | publications with EREG and Liver Diseases |
Organs/Tissues associated with EREG ELISA Kit
Blood | publications with EREG and Blood |
Lung | publications with EREG and Lung |
Skin | publications with EREG and Skin |
Liver | publications with EREG and Liver |
Muscle | publications with EREG and Muscle |
Mouth | publications with EREG and Mouth |
Intestine | publications with EREG and Intestine |
Brain | publications with EREG and Brain |
Kidney | publications with EREG and Kidney |
Lymph Node | publications with EREG and Lymph Node |